查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446480

臨床試驗設備和輔助解決方案市場規模、佔有率、趨勢分析報告：按產品、階段、地區、細分市場預測，2024-2030

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 131 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗設備和輔助解決方案市場的成長和趨勢：

Grand View Research, Inc.的最新報告顯示，2024年至2030年，全球臨床試驗設備和輔助解決方案市場預計將以8.1%的複合年成長率成長，到2030年將達到51億美元。

製藥和醫療領域的成長、臨床試驗的全球化以及研發費用的增加是推動市場的因素。然而，COVID-19大流行影響了全球市場，導致設備和輔助用品供應鏈放緩。 COVID-19大流行為臨床試驗環境帶來了重大變化。在 COVID-19 大流行導致全球臨床試驗停止之前，數百項臨床試驗正在進行中。然而，對新的和更好的治療方法的需求不斷成長，導致大流行後臨床試驗的數量增加。

近年來，臨床試驗程序有了很大的發展。複雜的臨床試驗為整個醫療保健供應鏈帶來了新的挑戰。現代研究經常涉及大量患者和患者亞群，以及許多國家和研究地點。因此，供應鏈經理在使用臨床試驗設備和輔助設施時面臨越來越多的挑戰。租賃醫療設備減少了儲存、檢索和處置的負擔。另一個重要的決策理由是設備租賃減少了獲得許可的臨床試驗施行地點所需的大量前期成本和大量投資。

大流行需要有效的治療方法和介入措施。 COVID-19 改變了臨床試驗的進行方式，促進了醫療保健的數位化以及最尖端科技和方法的採用。這種採用預計將推動市場成長。此外，製藥公司用於開發 COVID-19 創新治療方法的高研發支出進一步促進了市場成長。

臨床試驗設備和輔助解決方案市場報告要點

  • 由於大量的臨床試驗以及全球對高效物流服務的需求不斷增加，供應/物流產品領域在2023年佔據市場收益佔有率超過38.95%。
  • III期細分市場預計將在2023年佔據市場主導地位，並在2030年之前保持主導地位。 III 期試驗是發現新治療標準最有效的方法。
  • 由於該地區 CRO 以及製藥和醫療保健公司的增加，預計北美將在 2022 年引領全球市場，並在預測期內保持主導地位。
  • 由於亞太地區作為施行地點的重要性日益增加，預計在預測期內，亞太地區的臨床試驗設備和輔助解決方案市場將出現最快的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章臨床試驗設備和輔助解決方案市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗設備及輔助解決方案市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臨床試驗設備與輔助解決方案市場：產品評估與趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 全球臨床試驗設備和輔助解決方案市場（按產品前景）
  • 2018年至2030年市場規模、預測與趨勢分析
    • 採購
    • 供應物流
    • 服務
    • 其他

第5章臨床試驗設備及輔助解決方案市場：階段估計與趨勢分析

  • 2023年及2030年階段市場佔有率
  • 細分儀表板
  • 全球臨床試驗設備和輔助解決方案市場，分階段展望
  • 2018年至2030年市場規模、預測與趨勢分析
    • 階段1
    • 階段2
    • 第三階段
    • 第四階段
    • 其他

第6章 臨床試驗設備及輔助解決方案市場：區域估算與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測及趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere（MediCapital Rent）
    • Quipment SAS
    • IRM
    • Marken
    • Myonex
    • Yourway
Product Code: GVR-4-68039-533-5

Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends:

The global clinical trial equipment & ancillary solutions market size is expected to reach USD 5.10 billion by 2030, expanding at a CAGR of 8.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, the COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments were in progress before the pandemic was halted due to COVID-19 globally. However, the growing demand for new and better treatment options has improved the number of clinical trial in the post-pandemic.

The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.

The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 has further contributed to the market growth.

Clinical Trial Equipment & Ancillary Solutions Market Report Highlights:

  • The supply/logistics product segment dominated the market with a revenue share of more than 38.95% in 2023 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
  • The phase III segment dominated the market in 2023 and is expected to maintain its dominance through 2030. Phase III studies are the most effective approach to discovering a new treatment standard
  • North America led the global market in 2022 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
  • Asia Pacific is anticipated to witness fastest growth in the clinical trial equipment and ancillary solutions market during the forecast period as it is becoming an increasingly significant site for clinical trial investigations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Phase
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Phase outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Evolving Clinical Trials Needs
      • 3.2.1.2. Rising Investment in R&D
      • 3.2.1.3. Growing pharmaceutical & Medical Devices industry
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising Cost of Clinical Trials
  • 3.3. Clinical Trial Equipment & Ancillary Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
    • 4.4.1. Sourcing
      • 4.4.1.1. Sourcing market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Procurement
      • 4.4.1.2.1. Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2.2. Equipment
      • 4.4.1.2.2.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2.3. Ancillaries
      • 4.4.1.2.3.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.3. Rental
      • 4.4.1.3.1. Rental market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.3.1.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.3.2. Ancillaries
      • 4.4.1.3.2.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Supply/ Logistics
      • 4.4.2.1. Supply/logistics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Transportation
      • 4.4.2.2.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Packaging
      • 4.4.2.3.1. Packaging market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Others
      • 4.4.2.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Service
      • 4.4.3.1. Service market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Calibrations
      • 4.4.3.2.1. Calibrations market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Equipment Servicing
      • 4.4.3.3.1. Equipment servicing market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.4. Others
      • 4.4.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Phase Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Phase Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
    • 5.4.1. Phase I
      • 5.4.1.1. Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Phase II
      • 5.4.2.1. Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Phase III
      • 5.4.3.1. Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Phase IV
      • 5.4.4.1. Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. Colombia
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Colombia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Ancillare, LP
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Imperial CRS, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Woodley Equipment Company Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Thermo Fisher Scientific, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Parexel International (MA) Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Emsere (MediCapital Rent)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Quipment SAS
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. IRM
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Marken
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Myonex
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Yourway
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 16 France clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 31 China clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 35 India clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
  • Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
  • Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical trial equipment & ancillary solutions market: Market outlook
  • Fig. 14 Clinical trial equipment & ancillary solutions market: Competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical trial equipment & ancillary solutions market driver impact
  • Fig. 20 Clinical trial equipment & ancillary solutions market restraint impact
  • Fig. 21 Clinical trial equipment & ancillary solutions market strategic initiatives analysis
  • Fig. 22 Clinical trial equipment & ancillary solutions market: Product movement analysis
  • Fig. 23 Clinical trial equipment & ancillary solutions market: Product outlook and key takeaways
  • Fig. 24 Sourcing market estimates and forecast, 2018 - 2030
  • Fig. 25 Procurement market estimates and forecast, 2018 - 2030
  • Fig. 26 Equipment market estimates and forecast, 2018 - 2030
  • Fig. 27 Ancillaries market estimates and forecast, 2018 - 2030
  • Fig. 28 Rental market estimates and forecast, 2018 - 2030
  • Fig. 29 Equipment market estimates and forecast, 2018 - 2030
  • Fig. 30 Ancillaries market estimates and forecast, 2018 - 2030
  • Fig. 31 Supply/Logistics market estimates and forecast, 2018 - 2030
  • Fig. 32 Transportation market estimates and forecast, 2018 - 2030
  • Fig. 33 Packaging market estimates and forecast, 2018 - 2030
  • Fig. 34 Others market estimates and forecast, 2018 - 2030
  • Fig. 35 Service market estimates and forecast, 2018 - 2030
  • Fig. 36 Calibrations market estimates and forecast, 2018 - 2030
  • Fig. 37 Equipment servicing market estimates and forecast, 2018 - 2030
  • Fig. 38 Others market estimates and forecast, 2018 - 2030
  • Fig. 39 Other products market estimates and forecast, 2018 - 2030
  • Fig. 40 Clinical trial equipment & ancillary solutions market: phase movement analysis
  • Fig. 41 Clinical trial equipment & ancillary solutions market: phase outlook and key takeaways
  • Fig. 42 Phase I market estimates and forecasts, 2018 - 2030
  • Fig. 43 Phase II market estimates and forecasts, 2018 - 2030
  • Fig. 44 Phase III market estimates and forecasts, 2018 - 2030
  • Fig. 45 Phase IV market estimates and forecasts, 2018 - 2030
  • Fig. 46 Global clinical trial equipment & ancillary solutions market: Regional movement analysis
  • Fig. 47 Global clinical trial equipment & ancillary solutions market: Regional outlook and key takeaways
  • Fig. 48 Global clinical trial equipment & ancillary solutions market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America, by country
  • Fig. 55 North America
  • Fig. 56 North America market estimates and forecasts, 2018 - 2030
  • Fig. 57 U.S.
  • Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Canada
  • Fig. 60 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 61 Europe
  • Fig. 62 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 63 UK
  • Fig. 64 UK market estimates and forecasts, 2018 - 2030
  • Fig. 65 Germany
  • Fig. 66 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 67 France
  • Fig. 68 France market estimates and forecasts, 2018 - 2030
  • Fig. 69 Italy
  • Fig. 70 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 71 Spain
  • Fig. 72 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 73 Denmark
  • Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 75 Sweden
  • Fig. 76 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 77 Norway
  • Fig. 78 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 79 Asia Pacific
  • Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 81 China
  • Fig. 82 China market estimates and forecasts, 2018 - 2030
  • Fig. 83 Japan
  • Fig. 84 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 85 India
  • Fig. 86 India market estimates and forecasts, 2018 - 2030
  • Fig. 87 Thailand
  • Fig. 88 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 89 South Korea
  • Fig. 90 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 91 Australia
  • Fig. 92 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 93 Latin America
  • Fig. 94 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 95 Brazil
  • Fig. 96 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 97 Mexico
  • Fig. 98 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 99 Argentina
  • Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 101 Colombia
  • Fig. 102 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 113 Market share of key market players - Clinical trial equipment & ancillary solutions market